Granules India Limited — Updates, 05-11-2025: General Updates
05-11-2025 | 09:39 am
05-11-2025 | 09:39 am
Granules' US subsidiary received an FDA inspection report for its Chantilly facility. A pre-approval inspection for a new controlled substance product resulted in one observation, now resolved. This is a positive step for future product approval.
No comments yet. Be the first to comment!
